Brief: Zhaoke Ophthalmology Says New Drug Application Of Cyclosporine A Ophthamic Gel Accepted By Center For Drug Evaluation
June 8 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK :
* NEW DRUG APPLICATION OF CYCLOSPORINE A OPHTHAMIC GEL HAS
BEEN
ACCEPTED BY CENTER FOR DRUG EVALUATION
Further company coverage: 6622.HK
Recent news on Zhaoke Ophthalmology
See all newsBrief: Zhaoke Ophthalmology Says Its Facility In Guangzhou Obtains GMP Certification From Australia's TGA
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital